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Abstract
Background Patients with chronic conditions, such as heart failure, swim regularly and most rehabilitation exercises are 
conducted in warm hydrotherapy pools. However, little is known about the acute effects of warm water immersion (WWI) 
on cardiac haemodynamics in patients with chronic heart failure (CHF).
Methods Seventeen patients with CHF (NYHA I and II; mean age 67 years, 88% male, mean left ventricular ejection frac-
tion 33%) and 10 age-matched normal subjects were immersed up to the neck in a hydrotherapy pool (33–35 °C). Cardiac 
haemodynamics were measured non-invasively, and echocardiography was performed at baseline, during WWI, 3 min after 
kicking in the supine position and after emerging.
Results In patients with CHF, compared to baseline, WWI immediately increased stroke volume (SV, mean ± standard 
deviation; from 65 ± 21 to 82 ± 22 mL, p < 0.001), cardiac output (CO, from 4.4 ± 1.4 to 5.7 ± 1.6 L/min, p < 0.001) and 
cardiac index (CI, from 2.3 ± 0.6 to 2.9 ± 0.70 L/min/m², p < 0.001) with decreased systemic vascular resistance (from 
1881 ± 582 to 1258 ± 332 dynes/s/cm5, p < 0.001) and systolic blood pressure (132 ± 21 to 115 ± 23 mmHg, p < 0.001). The 
haemodynamic changes persisted for 15 min of WWI. In normal subjects, compared to baseline, WWI increased SV (from 
68 ± 11 to 80 ± 18 mL, p < 0.001), CO (from 5.1 ± 1.9 to 5.7 ± 1.8 L/min, p < 0.001) and CI (from 2.7 ± 0.9 to 2.9 ± 1.0 L/
min/m², p < 0.001).In patients with CHF, compared to baseline, WWI caused an increase in left atrial volume (from 57 ± 44 
to 72 ± 46 mL, p = 0.04), without any changes in left ventricular size or function or amino terminal pro B-type natriuretic 
peptide.
Conclusions In patients with CHF, WWI causes an acute increase in cardiac output and a fall in systemic vascular resistance.
Clinical trial registration ClinicalTrials.gov (Identifier: NCT02949544) https ://clini caltr ials.gov/ct2/show/NCT02 94954 
4?cond=NCT02 94954 4&rank=1.
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Introduction
Exercise training is recommended for patients with chronic 
heart failure (CHF) [1–4], not only to improve exercise 
capacity but also for its beneficial effects on morbidity and 
mortality [5–7]. Although symptom-limiting exercise is safe 
in patients with heart failure [8], factors such as advanced 
age [9, 10], and comorbidities such as osteoarthritis, hinder 
exercise training on a treadmill or a cycle in patients with 
CHF. Swimming is common in the United Kingdom and 
has the advantage of providing buoyancy to reduce impact 
on joints [11]. Swimming in patients with arthritis improves 
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mobility, strength and cardiovascular fitness without any 
joint discomfort [12].
Whether swimming is safe in patients with CHF has not 
been answered comprehensively in previous studies of water 
immersion or swimming [13]. When normal subjects are 
immersed up to the neck in water, the hydrostatic pressure 
forces approximately 700 mL of blood pooled in the periph-
ery to the cardiothoracic space [14]. The increased preload 
to the heart increases stroke volume by 34–50% in normal 
subjects [14, 15]. However, this increased preload to the 
failing heart may precipitate pulmonary oedema. Currently, 
only the Scottish guidelines on the management of CHF 
mention swimming to warn against it in patients with New 
York Heart Association (NYHA) class III and IV symptoms 
[4].
The aim of the present study was to assess the acute 
hemodynamic, echocardiographic and amino terminal pro 
B-type natriuretic peptide (NTproBNP) changes during 
warm water immersion (WWI) in patients with CHF.
Methods
Ambulatory patients with an established diagnosis of CHF, 
on stable treatment for more than 3 months were enrolled 
from a community heart failure clinic. Patients with severe 
symptoms (NYHA class IV), weight over 120 kilograms, 
hospitalised within last 6 weeks or with a contraindication 
to WWI (epilepsy, recent hypoglycaemia, intravenous line 
or urinary catheter) were excluded from the study. Controls 
were normal subjects, over 60  years of age, who were 
already consented to take part as healthy volunteers in a 
local observational research program. Normal subjects had 
to have a left ventricular ejection fraction (LVEF) ≥ 50% on 
echocardiography.
The research conforms to the Helsinki declaration and 
ethics approval was granted by an external research ethics 
committee. The trial was registered on the ClinicalTrials.gov 
website (Identifier: NCT02949544) and all participants gave 
their written informed consent.
Water immersion protocol
The study was conducted in a hydrotherapy pool on the hos-
pital site. The pool temperature was maintained between 33 
and 35 °C and the outside temperature was maintained at 
21 °C. A metal bed designed to be immersed in water was 
attached to a manual hoist fixed next to the pool. Partici-
pants remained in supine position on the bed throughout the 
study and the patients were immersed and removed from the 
water using the hoist. (Fig. 1) Supine position was chosen as 
this was the best position to mimic swimming posture and 
also enable non-invasive haemodynamic measurements and 
echocardiography whilst immersed.
Baseline measurements, including a blood sample for 
NTproBNP analysis, and echocardiography (GE Vivid E9, 
Hatfield, Hertfordshire, UK) were conducted after partici-
pants were comfortable on the bed for 10–15 min. A non-
invasive haemodynamic monitoring device (Nexfin, BMeye, 
Amsterdam, The Netherlands) was used to continuously 
Fig. 1  Study equipment. 
Echocardiography machine: GE 
Vivid E9, Hatfield, Hertford-
shire, UK. Non-invasive haemo-
dynamic monitoring device 
(Nexfin, BMeye, Amsterdam, 
The Netherlands) with an inflat-
able finger cuff was attached to 
the mid finger of participant’s 
left hand. Hydrotherapy pool 
(maintained at a temperature 
between 33 and 35 °C)
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monitor cardiac haemodynamics. This device has been 
validated against invasive methods of monitoring cardiac 
haemodynamics in studies of patients with heart failure and 
critically ill patients [16–18]. An inflatable finger cuff was 
attached to the mid finger of participant’s left hand (Fig. 1) 
and during immersion the left hand was rested on a floater to 
ensure the device remained out of the water. The device con-
tinuously recorded cardiac haemodynamics from baseline to 
the end of the study. The reference level for the non-inva-
sive haemodynamic device was at the surface of the water 
throughout, and thus very slightly higher than the level of 
the heart. The measurements outside the pool were made 
with the reference level in the same relative position before 
immersion. A non-invasive device (VENUS 2000 CVP 
monitor, Mespere LifeScience Inc, Waterloo, Canada) was 
used to measure central venous pressure (CVP) using a small 
adhesive neck sensor placed over the external jugular vein. 
The device uses near infrared spectroscopy to determine the 
pressure in the external jugular vein and its clinical use has 
been validated in critically ill patients with cardiovascular 
conditions, and in out-patients setting for patient with heart 
failure [19–21].
The participants were then gradually immersed up to their 
neck into the hydrotherapy pool in supine position. Echo-
cardiography was repeated at 1 and 15 min following WWI 
with the ultrasound probe covered with a light polythene bag 
to ensure it remained water proof. After 15 min of WWI, the 
participants were asked to perform gentle exercise (3 min 
of kicking at an speed of 40 repetitions per minute) whilst 
remaining in supine position on the bed. The exercises per-
formed was hip extension and flexion with a straight leg. At 
the end of 3 min of exercise, echocardiography was repeated. 
Once all the echocardiographic and haemodynamic readings 
were recorded the participants were lifted out of the water. 
Haemodynamic readings, symptom scores, blood sample 
for NTproBNP and echocardiography were repeated whilst 
participants remained in supine position on the bed 3 min 
after emerging from the hydrotherapy pool.
All the electric devices used were checked by University 
engineers to ensure they were safe for use near water. Addi-
tional circuit breaking sockets were installed in case of any 
power surges or short circuits.
From the non-invasive haemodynamic and central venous 
pressure monitoring devices, the following variables were 
recorded at baseline, 1 min WWI, 15 min WWI, 3 min after 
exercise and after 3 min recovery: heart rate (HR), blood 
pressure (BP), stroke volume (SV), cardiac output (CO), 
cardiac index (CI), systemic vascular resistance (SVR) and 
central venous pressure. An average of five measured values 
for each haemodynamic variable was taken. All echocardio-
graphic exams were performed by the lead cardiac sonog-
rapher in the Department of Academic Cardiology (AB), 
subsequently stored on DVDs, and finally reviewed off-line 
by a single experienced operator blind to the various phases 
of the study (PS).The following echocardiographic variables 
were measured: left ventricular end diastolic (EDV) and end 
systolic volumes (ESV), left ventricular ejection fraction 
(LVEF), left atrial diameter (LAD) and volume (LAV) tri-
cuspid annular plane systolic excursion (TAPSE), systolic 
tricuspid regurgitation (TR) pressure gradient, inferior vena 
cava (IVC) diameter. Patients’ modified Borg score, Cana-
dian cardiovascular society angina grading scale, fatigue 
symptom inventory symptom scores were taken at baseline 
and recovery.
Statistical analysis
Categorical data are presented as numbers and percentages; 
normally distributed continuous data as mean ± standard 
deviation (SD) and non-normally distributed continuous 
variables as median and interquartile range. The repeated 
measures ANOVA was used to assess the overall difference 
between related means of each variable and the Bonferroni 
correction was used for multiple testing errors. Log trans-
formation of NTproBNP was used, given its not normal dis-
tribution. Primary and secondary endpoints are shown in 
graphs. All analyses were performed on SPSS (V.23.0), and 
statistical significance was assumed at p < 0.05 (two tailed).
Results
Baseline characteristics of patients with CHF 
and normal subjects
Baseline characteristics of patients with CHF and normal 
subjects are shown in Table 1. All but one of the patients had 
NYHA class II symptoms. Normal subjects were of a similar 
age, 90% were male and baseline cardiac haemodynamics 
were similar to patients with CHF.
Haemodynamic changes with warm water 
immersion and exercise
In patients with CHF, and compared to baseline measure-
ments, WWI caused a significant, immediate (1 min) and 
sustained (after 15 min) increase in SV, CO, CI and decrease 
in BP and SVR, with no change in HR or CVP. The 3 min of 
kicking led to a further increase in HR, BP, CI and CO, with 
no change in SV, SVR or CVP (Figs. 2, 3).
In normal subjects, WWI caused a significant, immediate 
(1 min) and sustained (15 min) increase in SV, CO and CI 
with no change in HR, BP, SVR or CVP. The 3 min of kick-
ing led to an increase in HR, CO and CVP with no change 
in BP, SV, CI or SVR (Figs. 2, 3).
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Echocardiographic changes with warm water 
immersion and exercise
In patients with CHF, WWI for 15 min led to a significant 
increase in LAV. The 3 min of kicking led to an increase in 
estimated pulmonary artery systolic pressure (Figs. 4, 5).
In normal subjects, WWI for 15  min significantly 
increased left ventricular EDV. There were no significant 
changes in echocardiographic variables after 3 min of 
kicking (Figs. 4, 5).
Table 1  Baseline characteristics 
of patients with CHF and 
normal subjects
CHF chronic heart failure, BMI body mass index, SBP systolic blood pressure, NYHA New York Heart 
Association, IHD ischaemic heart disease, COPD chronic obstructive pulmonary disease, HR heart rate, 
LVEDV left ventricular end diastolic volume, LVEF left ventricular ejection fraction, LAD left atrial diam-
eter, LAV left atrial volume, TAPSE tricuspid annular plane systolic excursion, TR tricuspid regurgitation, 
IVC inferior vena cava, Hb haemoglobin, NTproBNP amino terminal pro brain type natriuretic peptide, 
ACEi angiotensin converting enzyme inhibitor, ARB angiotensin receptor blocker, MRA mineralocorticoid 
receptor antagonist, CRT cardiac resynchronization therapy
Baseline characteristic of participants
Variables Patients with CHF (N = 17) Normal subjects 
(N = 10)
p value
Demographics
 Age 67 (12) 70 (10) 0.39
 Male (%) 15 (88) 9 (90) 0.89
 Weight (kg) 78 (13) 73 (10) 0.37
 BMI (kg/m2) 26 (3) 24 (3) 0.19
 SBP (mmHg) 129 (16) 143 (30) 0.14
NYHA class
 I (%) 1 (6) 10 (100) < 0.001
 II (%) 16 (94) 0 (0)
Medical history
 Hypertension (%) 4 (24) 2 (20) 0.84
 IHD (%) 12 (71) 0 (0) < 0.01
 Diabetes (%) 2 (12) 3 (30) 0.26
 COPD (%) 2 (12) 0 (0) 0.28
Electrocardiogram
 Sinus 14 (82) 10 (100) 0.17
 HR (beats/min) 65 (10) 66 (12) 0.87
Echocardiography
 LVEDV (mL) 189 (64) 88 (37) < 0.001
 LVEF (%) 33 (9) 58 (8) < 0.001
 LAD (mm) 4 (0.9) 3.5 (0.6) 0.15
 LAV (mL) 57 (44) 36 (22) 0.2
 TAPSE(mm) 1.9 (0.6) 2.7 (0.5) 0
 Peak TR gradient (mmHg) 18 (9) 15 (8) 0.49
 IVC (cm) 1.6 (0.5) 1.4 (0.4) 0.31
Blood results
 Hb (g/L) 13.4 (1.3) 14.2 (1.2) 0.09
 Creatinine (µmol/L) 114 (24) 73 (13) < 0.001
 NTproBNP (ng/L) 558 (323–1140) 82 (42–119) < 0.01
Medications and devices
 ACEi/ ARB (%) 15 (88) 1 (10) < 0.001
 Beta blocker (%) 15 (88) 0 (0) < 0.001
 MRA (%) 13 (77) 0 (0) < 0.001
 Loop diuretic (%) 14 (82) 0 (0) < 0.001
 CRT (%) 7 (41) 0 (0) 0.02
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NTproBNP and symptom changes with warm water 
immersion and exercise
There was no significant difference in NTproBNP levels 
between baseline and recovery in patients with CHF [558 
(IQR: 323–1140) to 642 (IQR: 309–1187) ng/L, p = 0.21] or 
normal subjects [82 (42–119) to 84 (43–118) ng/L, p = 0.08]. 
None of the subjects experienced any adverse events during 
water immersion. None of the patients reported any change 
in any symptom (shortness of breath, chest pain or fatigue) 
during immersion or recovery.
Discussion
We found that WWI in patients with CHF increases car-
diac output. The mechanism for the haemodynamic changes 
is presumably that hydrostatic pressure increased cardiac 
preload and atrial volumes. WWI caused systemic vasodila-
tion, leading to a fall in blood pressure which, in turn, causes 
a decreased left ventricular afterload.
Our results are similar to those reported by other research-
ers. In a study of nine patients with CHF, WWI (34 °C) up to 
the xiphoid process increased central venous pressure, and 
as in our study, increased left atrial diameter (by echocardi-
ography), CI and SV index with a decrease in SVR [22]. In a 
study of 13 patients with CHF (mean LVEF 32%) and more 
severe symptoms (77% in NYHA class 3), WWI (33–34 °C) 
up to the sternal notch increased LVEF, SV and CO but also 
worsened left ventricular diastolic function (increasing trans 
mitral Doppler E/A ratio), with no effect on blood pressure 
[23]. 5 min of seated reciprocal unilateral knee-extensions 
in water increased CO, SBP and HR, and was tolerated by 
patients [23]. Similarly, in a study of 18 patients with CHF 
(LVEF 31%, 50% in NYHA class 3), WWI (34 °C) signifi-
cantly increased SV and CO but decreased HR, BP and SVR. 
Fig. 2  Cardiac haemodynamic changes during WWI measured by 
non-invasive haemodynamic monitoring device (Nexfin, BMeye, 
Amsterdam, The Netherlands). Cardiac haemodynamic changes were 
measured at baseline, 1  min WWI, 15  min WWI, 3  min after WW 
exercise, at recovery. HR heart rate, SBP systolic blood pressure, SVR 
systemic vascular resistance, SV stroke volume, CO cardiac output, 
CI cardiac index, WWI warm water immersion, WW warm water, 
CHF chronic heart failure
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WWI also led to an increase in left ventricular end diastolic 
and systolic volumes, estimated pulmonary capillary wedge 
pressure and left ventricular ejection fraction [24].
All the previous studies of WWI on cardiac haemody-
namic had patients in sitting or standing positions during 
WWI. We positioned the participants in supine position 
because this better replicates the posture during swimming 
[22–24].
Warmer or colder water temperatures might lead to more 
pronounced, or different effects, on cardiac haemodynam-
ics and heart function. Hot water immersion (41 °C) for 
10 min significantly decreased left ventricular and atrial 
size, increased LVEF and decreased mitral regurgitation in a 
study of 34 patients with CHF and severe symptoms (LVEF 
25%, 94% in NYHA class III/IV). The changes persisted for 
30 min after emerging from water [25]. Mean pulmonary 
artery pressure, mean pulmonary capillary wedge pressure, 
and mean right atrial pressure rose substantially during hot 
water immersion but did not cause any symptoms. In two 
studies, cold-water immersion (12–22°C) for a few seconds 
Fig. 3  CVP changes during WWI. CVP changes were measured at 
baseline, 1  min WWI, 15  min WWI, 3  min after WW exercise, at 
recovery. CVP central venous pressure, WWI warm water immersion, 
WW warm water, CHF chronic heart failure
Fig. 4  Left cardiac variable changes during WWI. Left cardiac vari-
ables changes were measured at baseline, 1 min WWI, 15 min WWI, 
3  min after WW exercise, at recovery. EDV End diastolic volume, 
ESV end systolic volume, LVEF left ventricular ejection fraction, 
LA left atrial, WWI warm water immersion, WW warm water, CHF 
chronic heart failure
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increased cardiac output and blood pressure but change in 
heart rate was variable [26, 27].
Swimming is a popular form of exercise in the United 
Kingdom [11]. Whether swimming is safe in patients with 
heart failure is still not known [13, 14]. Swimming-induced 
pulmonary oedema (SIPE) is a rare occurrence seen in ath-
letes undertaking strenuous exercise [28, 29]. In all studies 
of water immersion in patients with CHF there have been no 
reports of SIPE, although the time of water immersion and 
exercise has been limited to a few minutes in a controlled 
environment.
In previous studies, warm water immersion up to the 
neck in standing position for 5–10 min, has increased cen-
tral venous pressure [30, 31]. We found that central venous 
pressure did not increase and pulmonary artery systolic 
pressure increases only after 3 min of gentle exercise in 
patients with CHF (without precipitating any symptoms), 
but not in normal subjects. The pulmonary artery systolic 
pressure rapidly returned to baseline after WWI. Reas-
suringly, the haemodynamic changes did not lead to an 
increase in NTproBNP plasma levels. In studies looking 
at the effect of WWI on natriuretic peptides in normal 
subjects, atrial natriuretic peptide significantly increased 
without any change in brain natriuretic peptide [32, 33]. 
There have been no studies looking at the acute change in 
natriuretic peptides during water immersion in patients 
with heart failure. Whether prolonged immersion or swim-
ming causes a more sustained increase in systolic pulmo-
nary pressure and symptoms in patients with CHF requires 
further studies.
Limitations
Our study was conducted in a controlled, indoor thermon-
eutral hydrotherapy pool, and therefore, the results cannot 
be translated to swimming in different environmental con-
ditions. The studied population was small, and patients had 
only mild symptoms; thus, results of this study cannot be 
generalised to all patients with CHF, particularly to those 
with more severe disease. Although majority of the patients 
swim in prone, we were limited to investigate patients in 
supine position to enable echocardiography. The workload 
was not standardized and not adjusted for maximal exercise 
capacity. It was chosen to allow all participants to be able to 
conduct 3 min of exercise with continuous haemodynamic 
monitoring. We did not measure NTproBNP levels after a 
few hours from completing the study, or troponin levels, 
which might have provided further information about any 
delayed effect of WWI with exercise on the myocardium.
Conclusion
In patients with CHF, WWI causes an acute increase in car-
diac output and a fall in vascular resistance. The changes 
were well-tolerated. Whether swimming can be recom-
mended as alternative to other forms of exercise or reha-
bilitation in patients with CHF needs to be studied further.
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Fig. 5  Right cardiac variable changes during WWI. Right cardiac 
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lar plane systolic excursion, TR tricuspid regurgitation, IVC inferior 
vena cava, WWI warm water immersion, WW warm water, CHF 
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